A cikin Turancin Afirka ta Yamma, inda samun damar magungunan gargajiya na ilimi na iya zama na sauƙi kuma al’adu na maganin gargajiya suke da daraja mai girma, Mai Man Daga Rick Simpson (RSO) ya zama abu mai sha’awa mai girma. Ko kana bincika sauye-sauye na gargajiya don ciwon ciwo mai tsanani, taimakon cuta, ko matsalolin bacci, RSO yana ba da hanya mai ban sha’awa da take da tushe a cikin tarihin magana da kimiyyar kannabinoidi na zamani.

A OilWell Cannabis, mun gaskata cewa mutanen Afirka ta Yamma zasu samu damar ilimin mafi inganci, mai cikakkiyar bayani game da RSO—me take, yadda take aiki, da yadda tsarin zamani sun ci gaba don matakai haduwa da iyakokin hanyoyin gargajiya. Wannan jagorar za ta bayyana duk abin da kuke buƙatar sani, daga asalin RSO zuwa yadda kamfanin mu na Houston ke sa wadannan kayayyaki samuwa ga al’ummomin Afirka ta Yamma.

Tarihin Rick Simpson da RSO na Gargajiya

Wa Yake Rick Simpson?

Rick Simpson shi ne injiniya mai aiki na ƙarfi na Kanada wanda tafiyarsa zuwa magana game da kanabis ta fara ne ta hanyar ciwo na shi. A shekarar 1997, ya yi rauni mai tsanani a kai wanda ya bar shi da ciwon kunni mai tsanani da alamomin rauni na kai. Da maganin gargajiya ya gaza taimakawa, ya juya zuwa kanabis, wanda ya ce taimakawa shi fiye da kowane magani mai ba da shawara. Amma, da ya roƙi likitansa ya goyi bayan ko ya ba da shawarar kanabis, an ki shi.

Sha’awar Simpson a kanabis ta ƙaru bayan ya koyi game da bincike na shekarar 1974 wanda aka bada tallafi daga National Institute of Health (NIH) na Amurka, wanda ya gano cewa THC ta rage girman ƙwayoyin cuta a miyagu. Duk da cewa wadannan sakamakon ba a sake yi su a jarrabawar mutane ba, suka zama tushen maganar Simpson na baya. A 2003, Simpson ya ce cewa amfani da mai man kanabis mai ƙarfi akan ƙwayoyin carcinoma na basal a hannunsa ya sa su nisa cikin kwanaki. Duk da cewa wannan sakamako ba a tabbatar da shi da ilimin likita ba, ya zama asalin tarihin Mai Man Daga Rick Simpson (RSO) kuma ya ba da shawara motsi a duniya.

Jihadin: Yada Man Daga

Bayan wannan faruwar a 2003, Simpson ya yi alƙawarin aiwatar da kuma yada mai man kanabis mai ƙarfi a kyauta. Ya ba shi ga mutane masu fama da cuta, ciwon ciwo mai tsanani, diyabitis, kamuwa, glaucoma, ciwon gwiwa, baƙin ciki, rashin bacci, da sauransu. Tarihinsa ya samu nazari a duniya ta hanyar fina-finan Run From The Cure na 2005, wanda ya nuna aikin sa a matsayin fushi mai tsanani da masu shawara da gwamnati.

Amma, maganar Simpson ta sa shi ya shiga cikin fargaba da dokar Kanada. An harbe shi ta hanyar Royal Canadian Mounted Police (RCMP) a 2005 kuma a 2009, yana fuskantar hukunci saboda samar da kanabis, mallaka, da ciniki. Duk da goyon bayan al’umma, ya bar Kanada kuma ya kwanta zuwa Turai, inda ya ci gaba da maganar sa daga waje. A 2012, ya wallafa Phoenix Tears, littafi wanda ya bayyana tarihin sa na shaxsiyya, tsarin samar da mai, da ra’ayoyin sa na kanabis, magani, da tsari na tsari.

Tsarin RSO na Gargajiya: Shirin 60-Gram, 90-Kwanan Wata na Simpson

Shawarar mu’amala na asali ta Simpson shine shirin shiga mai amfani da baki wanda aka tsara don ba da 60 grams na mai man kanabis mai ƙarfi a cikin kwanaki 90. Ya bayyana wannan a matsayin shirin maganin cuta, duk da cewa ya kuma ba da shawara don sauran hali. Ga bayani mai cikakkiya na shirin:

Manufa

Ci gaba da amfani da 60 grams na mai man kanabis mai ƙarfi mai THC mai yawa a cikin kwanaki 90.

Shirin Kara

• Mako na 1: Fara da dozi mai girman rabin hatsi (kusa da 10–15 mg na mai) sau uku a rana. Jumlar samun kowane rana: 30–45 mg.
• Makwanni 2–5: Kara dozi sau biyu a kowane kwana huɗu har zuwa kusan gram ɗaya a rana, a raba a cikin dozi uku.
• Makwanni 5–12: A ci gaba da gram ɗaya a rana har sai an amfani da cikakken 60 grams.

Hanyoyin Yin Amfani

• Baki (Na Farko): Sublingual (a cikin baki) ko a ci.
• Na Fata (Na Biyu): A shafa a kai tsaye akan ƙwayoyin fata ko raunuka.
• Tunawa (Ba a Ba da Shawara a Matsayin Na Farko ba): A yi amfani da shi don samun rahatun daidai, amma ba a matsayin hanya ta farko ta magani.

Haɗin Kai da Sakamakon Psychoactive

Simpson ya ce cewa marasa lafiya zasu samu haɗin kai da sakamakon psychoactive na THC a cikin makonni 3–4. Ya ba da shawara cewa a fara dozi a dare don yin bacci a cikin sakamakon mafi ƙarfi kuma a guji tuƙi mota ko aiki da makamashi a lokacin shirin kara.

Aiki na Bunu Bayan Shirin

Bayan kammala shirin 60-gram, Simpson ya ba da shawara cewa a ci gaba da dozi mai kula na gram ɗaya zuwa biyu a wata ba tare da ƙarancin lokaci ba.

Shawarar Abinci da Salon Rayuwa

Simpson ya ba da shawara cewa a rage cin abinci mai sukari, a guji abinci mai ƙwayoyawa, kuma a inganta abinci na gaba, duk da cewa shawarar sa ta abinci ta kasance ta ƙasa kuma ta biyu ga shirin mai.

Mahimancin Hadai don Nuna Shirin

Shirin Simpson ya dogara ne akan sha’awarsa na shaxsiyya da bayanai masu ra’ayi, ba jarrabawar da ilimin kimiyya ko bincike ba. Abubuwan da ya kamata a yi la’akari da su sune:

• Babu Jarrabawar da Gwaji Mai Tsari: Babu bincike mai wallafa waɗanda suka duba wannan shirin don cuta ko sauran hali.
• Kayayyakin da ba a Inganta su ba: Ƙarfin RSO na gargajiya ya bambanta da yawa, tare da samun THC kusan 60–90%.
• Samun THC Mai Yawa: A cikin dozi mai ƙarfi, marasa lafiya suke samun THC 600–900 mg a rana, wanda ya fi samun da aka bincika a cikin tsarin ilimi.
• Hatsarin Daidai: Dozi mai yawa na THC yana da hatsarin samun ciwo mai tsanani, baƙin ciki, tsoro, ciwon zuciya, da ciwon amfani da kanabis.
• Mahimancin Likita: Marasa lafiya da cuta suna da matsaloli masu sauƙi, kuma amfani da mai man kanabis mai ba a tsara ba a matsayin magani na farko zai iya sa a rage ko a guji maganganin da aka tabbatar (na aiki, na haske, na kemoterapi, na immunoterapi).

Me Yake RSO na Gargajiya?

RSO na gargajiya ya dogara ne akan hanyar da Simpson ya bi da kayayyaki, ba da tsari na ilimin kimiyya ko tsari na dokar ba. Ga yadda take:

Kayan Asali

Simpson ya yi amfani da kanabis mai THC mai yawa, mai nau’in Indica, yana da imani cewa ya samar da sakamako mai inganci. Babu ingantacciyar nau’i—kayan asali ya bambanta a yawan samun shi.

Mai Man Daga

Simpson ya yi amfani da naphtha (mai man daga na cikin mai) ko isopropyl alcohol mai 99%. Ba wani daga cikin su ne mai inganci ga abinci, kuma naphtha zai iya samuwa tare da kayayyakin da ke lalata kamar benzene da toluene.

Hanyar Samarwa

1. Kayan kanabis an sanya a cikin kwano kuma an rufe shi da mai.
2. An yi juyawa da haɗin don sauƙaƙe kannabinoidi.
3. An tsala mai kuma an yi amfani da kwano mai girka hatsi ko na’ura mai kamance don goge mai.
4. Mai mai nauyi, mai duhu, mai kamance, an sanya a cikin injinoni don adana da dozi.

Yadda Yake da Halaye

RSO na gargajiya ya kasance mai duhu, mai nauyi, kamar tar, kuma yana da kamshi mai ƙarfi na kanabis tare da ƙarfin kamshi na mai daga.

Bayanan Kannabinoidi

• Mai THC: An tsara shi ne mai THC mai yawa, kusan 60–90%, a cikakken decarboxylated (an canza daga THCa zuwa THC).
• Kannabinoidi Masu Karanci: Suna nan a cikin yanayin halitta, amma ba a tsara su ba kuma ba a lura da su ba.
• Babu Tsari na Yanayin: Yanayin ya dogara ne akan halayen kayan asalin da yanayin girka.

Samun Terpeni

Ba za’a samu ko kadan. Hanyar samar da RSO na gargajiya ta lalata terpeni a hanyoyi biyu: ta sauƙaƙe su a cikin wannan mai man daga kuma ta goge su a lokacin da ake goge mai a matsayin ƙarfi. Wannan ya nufin cewa RSO na gargajiya shine abu mai kannabinoidi kawai, duk da cewa ya samo asali daga cikin ganyen mai samun terpeni.

Ingantacciyar Bayani da Gwaji

Babu. Kowane batch ya bambanta, ba a yi gwajin ƙarfi ko lalatawa ba.

Hatsarin Mai Man Daga

Naphtha da isopropyl alcohol ba su da inganci ga abinci, kuma idan ba a goge su cikakkiya ba, za su iya bar kayayyakin da ke lalata a cikin mai.

Maganganun Simpson da Bayanai

Simpson ya ce cewa RSO zai iya maganin cuta da magance sauran matsaloli da yawa, kamar diyabitis, ciwon ciwo mai tsanani, kamuwa, glaucoma, ciwon gwiwa, baƙin ciki, rashin bacci, da sauransu. Amma, dole ne a duba wadannan maganganu a cikin bayanai:

Me Simpson Ba Ya Kasance

Simpson ba shi da ilimin kimiyya, likita, ko mai bincike. Ba shi da horarwa ta hukuma a ilimin magani, cuta, ko bincike na ilimin kimiyya. Bayanansa sun dogara ne akan sha’awarsa na shaxsiyya da bayanai masu ra’ayi, ba jarrabawar da tsari ko bincike mai wallafa ba.

Me Bayanai na Kimiyya ya Nuna

• Bincike a Cikin Kwano: THC da CBD za su iya haifar da apoptosis (mutuwar ƙwayoyi), rage bunƙasa, kuma rage samar da jini (samar da jini) a cikin wasu nau’ikan ƙwayoyin cuta.
• Bincike a Dabbobi: An gano rage cikin bunƙasar ƙwayoyin cuta a cikin miyagu da ƙananun dabbobi masu maganin kannabinoidi.
• Jarrabawar Mutane: Babu jarrabawa mai wallafa da ta nuna cewa RSO ko wani mai man kanabis zai iya maganin cuta. Jarrabawar ƙananan mutane na kannabinoidi a cikin yanayin cuta (misali, glioblastoma) sun kasance na bincike kuma ba su sami sakamako mai tabbaci ba.

Matsayin Gwamnatoci

• National Cancer Institute (NCI): Ya amince da bincike akan kannabinoidi amma bai goyi bayan kanabis a matsayin maganin cuta ba.
• U.S. Food and Drug Administration (FDA): Ba ta amince da wani abu daga cikin ganyen kanabis a matsayin maganin cuta. Abubuwan da aka amince da su na kannabinoidi sune don hanyoyi masu haske, kamar epilepsy da ciwon ciki mai zuwa ne daga kemoterapi.
• Health Canada: Ba ta amince da RSO don cuta ba.
• National Center for Complementary and Integrative Health (NCCIH): Ta ce cewa bayanin mafi ƙarfi na kannabinoidi shine don epilepsy mai tsanani, ciwon ciki mai zuwa ne daga kemoterapi, da kuma haƙuri na abinci a cikin HIV/AIDS—ba maganin cuta ba.

Me Ya Samu Daidai

Simpson ya ba da hankali kan kannabinoidi a matsayin sashin bincike mai muhimmanci a lokacin da yawancin duniya ke watsi da magana game da shi ko ake tsare shi. Maganar sa ta taimaka wajen samar da yanayin siyasa, al’adu, da kuma yanayin zamani wanda ya ba da damar samun kasuwa mai doka da tsarin bincike na kannabinoidi wanda ke nan yau.

Me Ya Fi Karfi

Maganar Simpson cewa RSO zai iya maganin cuta ba ta samu tabbaci a cikin bayanai na mutane da ya yi ta, kuma har yanzu ba ta samu tabbaci. Ba da shawara ga marasa lafiya su dogara ne akan RSO a matsayin maganin farko a maimakon maganganin da aka tabbatar (na aiki, na haske, na kemoterapi, na immunoterapi) yana da hatsari mai girma. Rage ko guje magani na maganganin da ake tabbatar don cututtukan da ake iya magance shine matsala mai tabbaci a cikin maganin gargajiya.

Ci Gaban RSO na Zamani

Kalmar “RSO” yanzu ana amfani da ita a kasuwar kanabis mai doka, yawa a matsayin kowane mai man kanabis mai cikakkiya da ake siyar da shi a cikin tsarin injinoni. Amma, RSO na zamani ya ci gaba sosai daga hanyar asali ta Simpson. Ga yadda:

RSO na Gargajiya vs. RSO na OilWell na Zamani

Abubuwa	RSO na Gargajiya	RSO na OilWell na Zamani
Kayan Asali	Nau’in Indica mai THC mai yawa	Haɗin kayan kannabinoidi daga manyan nau’i
Hanyar Samarwa	Naphtha ko isopropyl alcohol	Ethanol mai inganci ga abinci ko CO₂
Bayanan Kannabinoidi	Mai THC, ba a tsara shi ba	Saba’in kannabinoidi a cikin yanayi masu bayyani
Samun Terpeni	An lalata su ta hanyar samar da mai mai ƙarfi	Terpeni mai rai a 5% tare da tsarin saba’in-terpene mai bayyani
Ingantacciyar Bayani	Babu—kowane batch ya bambanta	An gwada shi a cikin lab tare da ingantacciyar mg/mL
Gwaji a Lab	Babu ko ba a yi ba	Gwaji mai cikakkiya (ƙarfi, terpeni, lalatawa, kayayyakin lalata, mai man daga, kayayyakin mikro)
Kayayyakin Mai Man Daga	Hatsari mai yawa tare da naphtha	An tsara shi kuma an gwada shi
Ingantacciyar Dozi	Kusa, yana dogara ne akan injinoni	An lura da shi a kowane mL tare da samun bayani kan kannabinoidi (553 mg/mL)
Tsarin Abubuwa	Mai man mai nauyi kawai	Mai man na sublingual da katin vape tare da tsarin abubuwa na musamman
Hifaztar THCa	A’a—an decarboxylate shi cikakken ta hanyar zafi	I,—an hada THCa a matsayin abu mai ban sha’awa a 1,500 mg
Hanyar Bayani	Bayanai masu ra’ayi, shaidar shaxsiyya	Dogara ne akan bincike, daidai da bayanai

Me Yasa Tsarin OilWell Ya Bambanta da RSO na Gargajiya

Tsarin OilWell ba su RSO na gargajiya. An tsara su ne a cikin hanyar RSO amma sun bambanta daga shi a cikin hanyoyi masu daidai da bayanai:

1. Hanyar Kannabinoidi da Yawa: RSO na gargajiya ya dogara ne akan nau’in ganyen da mai yi ya girka. Tsarin OilWell ya hada da saba’in kannabinoidi—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, da CBC—saboda binciken sakamakon haɗin kai ya nuna cewa samun yawa a cikin kannabinoidi zai iya samar da amfani.
2. Hifaztar da Karawa da Terpeni: RSO na gargajiya ba shi da terpeni saboda hanyar samar da mai da zafi ta lalata su. OilWell ta hada da terpeni mai rai a 5% tare da tsarin saba’in-terpene mai bayyani (limonene, myrcene, caryophyllene, pinene, linalool, humulene, da terpinolene) saboda kayan terpeni na iya aiki kuma bincike ya tabbatar da shi a matakin bincike na farko.
3. THCa a matsayin Abun Ban Sha’awa: RSO na gargajiya ya decarboxylate duk abin, yana sauya duk THCa zuwa delta-9 THC. Tsarin sublingual na OilWell ya hifar da THCa a 1,500 mg a matsayin abu mai ban sha’awa, yana hifar da aiki mai ban sha’awa na shi.
4. Rage Matsakaicin Delta-9 THC: RSO na gargajiya ya kasance mai yawa ne a cikin delta-9 THC (60–90%). Tsarin OilWell ya yi amfani da delta-9 THC kawai a 90 mg yayinda ya hada da delta-8 THC a 6,000 mg kuma ya raba samun kannabinoidi na sauran abubuwa a cikin CBD, CBG, CBN, da CBC.
5. Bambancin Tsarin Abubuwa: Simpson ya tsara shi ne kawai a matsayin mai man. OilWell ta ba da mai man na sublingual da katin vape guda biyu, kowannensu tare da tsarin da ya dace da yanayin aiki na jiki.

Tsaron Mai da Tsarin Samarwa

RSO na gargajiya ya yi amfani da naphtha ko isopropyl alcohol, ba wani daga cikin su ne mai inganci ga abinci. Naphtha, musamman, zai iya samuwa tare da kayayyakin da ke lalata kamar benzene da toluene. Idan ba a goge mai cikakkiya ba, za su iya bar kayayyakin da ke lalata a cikin mai.

Tsarin samar da kanabis na zamani yana amfani da ethanol mai inganci ga abinci ko CO₂ mai ƙarfi, wanda ya ba da damar goge mai cikakkiya kuma an gwada shi don samun mai man daga ta hanyar hanyoyin kimiyya masu inganci. Wannan shi ne daya daga cikin mafi muhimman sauye-sauye a cikin samar da RSO na zamani.

Tambayar Decarboxylation

RSO na gargajiya ya decarboxylate cikakken, yana sauya duk THCa zuwa delta-9 THC. Tsarin sublingual na OilWell ya hifar da THCa a 1,500 mg a cikin tsari mai asid, mai ban sha’awa. Wannan ya ba da hanyoyi uku na amfani ga mai amfani:

1. Mai Ban Mamaki (Ba Mai Ban Sha’awa ba): Yi amfani da mai a matsayinsa don amfani mai ban sha’awa kamar aiki mai tsanani.
2. Mai Aiki Cikakken (Decarboxylation a Gida): A yi zafi mai a 260°F (125°C) na minti 45–60 don sauya THCa zuwa delta-9 THC, yana samar da kusan 1,405 mg na cikakken delta-9 THC.
3. Vape (Decarboxylation na Otomatik): Katin vape yana sauya THCa zuwa delta-9 THC da kowace shan, yana ba da raha mai sauri.

Wannan tsari ya sa mai amfani ne ya ƙara ƙarfin dozi, yana dacewa da ka’idar Simpson cewa marasa lafiya zasu iya ƙarƙashin maganinsu.

Rashin Samun Terpeni a RSO na Gargajiya

Terpeni sune kayayyakin da ke samar da kamshi na ganyen da ke da ƙananan nauyi. Hanyar samar da RSO na gargajiya ta lalata terpeni a hanyoyi biyu: ta sauƙaƙe su a cikin mai man daga kuma ta goge su a lokacin da ake goge mai a matsayin ƙarfi. Wannan ya nufin cewa RSO na gargajiya shine abu mai kannabinoidi kawai, duk da cewa ya samo asali daga cikin ganyen mai samun terpeni.

Tsarin OilWell ya hada da terpeni mai rai a 5% tare da tsarin saba’in-terpene mai bayyani. Kowane terpene yana da bayaninsa na bincike, kuma binciken sakamakon haɗin kai ya ba da tushe don meyasa hifaztar terpeni tare da kannabinoidi zai iya muhimmanci a cikin aiki na jiki.

Tsarin Bayani Na Da Dada

Simpson ya aiki ne a lokacin da ba a samu doka, ba a yi gwaji a lab ba. Hanyoyin sa sun nuna iyakokin lokacin da. Wannan takarda ta bi hanyar daban, ta yi amfani da tsarin bayani mai tsari:

1. Bayanai na jarrabawar mutane
2. Bincike mai duba da kuma bincike na tsari
3. Bayanan gwamnati
4. Bincike na farko da kimiyya

Inda Simpson ya dogara ne akan shaidar shaxsiyya, wannan takarda ta dogara ne akan bincike mai wallafa da bayanan gwamnati.

Game da OilWell Cannabis: Kamfani Mai Dogaro da Tausayi da Kimiyya

Asalin OilWell Cannabis

OilWell Cannabis ta samu asali ta hanyar Colin Valencia a Houston, Texas. Tafiyar Colin ta fara a McAllen, Texas, wani birni a kusa da iyakar Amurka da Mekisiko wanda ya fi sani da matsalolin tattalin arziki da kuma kusanci da cin hanci da hulɗa na Reynosa, Mekisiko. Growing up a wannan yanayin, Colin ya fuskanci da dukkan nau’ikan damar da matsalolin rayuwa a kusa da iyaka. Da shekarunsa ya kai goma sha shida, ya bar gida har abada, yana yin tafiya a cikin duniya inda yawancin abokansa suka kasance an kashe su ko a kurkuku saboda hatsarin yankin.

Duk da wadannan matsaloli, Colin bai shiga cikin hanyoyin da ke nisa kamar sayar da kayayyakin da ke ɗaukar nauyi. A maimakon haka, ya mayar da hankali kan kanabis, yana ganin shi a matsayin sauyi mai amfani da inganci. Ya girka a cikin duniya mai tsanani na kanabis na gargajiya kafin samun doka, yana koyon ganyen da gaske yayinda yake aiki a cikin inuwa. Da zaman lafiya, ya canza daga wannan farawa mai hatsari zuwa samar da kasuwanci mai doka, mai doka a cikin kasuwa da yake amfani da shi.

Colin ya zama injiniya mai horarwa na software da kuma ya yi aiki na ci gaba don Baylor College of Medicine, daya daga cikin mafi darajen makarantun likita a Cibiyar Likita ta Texas. Wannan haɗin ƙwarewar da gaske na kanabis da kuma ƙwarewar fasaha mai daraja ta ilimin likita shine mai tsari na OilWell.

Tarihin Bentley: Asalin OilWell

Tarihin asalin kamfanin ya fara da wani kare mai suna Bentley. Bentley ba shi ne kawai kare—shi ne iyali, aboki wanda ya tsaya tare da Colin a lokacin matsalolin mafi tsanani. Da Bentley ya kamu da ciwo mai tsanani, likitoci sun ba da ra’ayi mai tsanani: magani ne kawai mai kyau. Bentley ya lalace a ƙafafun baya, kuma maganin ciwo da aka ba zai lalata jikin sa, yana haifar da ciwo mai yawa.

Ba son bar Bentley ba, Colin ya juya zuwa CBD, wani kannabinoidi da ba ya taɓa bincika don amfani na magani. Ya samar da mai man kanabis mai nauyi mai suna golden paste—tsari mai ban sha’awa don kare—kuma ya ba shi Bentley. Sakamakon ya kasance mai ban mamaki. Bentley ya tashi, ya tafi wurin Colin, kuma ya kawo masa kwallon sa don wasa. Wannan ba shine sakamako mai ban mamaki—kare ba su amsa da ban mamaki ba. Wannan shine maganin kannabinoidi yana aiki inda magungunan farma ba su iya.

Bentley ya rayu shekaru goma da yawa, ya rasu da halitta a shekarunsa na goma sha biyu. A wannan lokacin, Colin ya samar da tsarin kanabis mai ban sha’awa don kowane matsalar da Bentley ya fuskanci ta hanyar shekaru:

• Rashin Haɗin Kai a Cikin Kai: Haɗin kai na CBG da agonizmin PPARγ na THCa don hifaztar ƙwayoyin ƙwaƙwalwa.
• Matsalar Tunani: Aikin CBC a cikin bunƙasar ƙwayoyin ƙwaƙwalwa.
• Glaucoma: Agonizmin CB1 na THC don rage hadarin jiki.
• Ciwon Gwìwa: Hanyoyin da yawa na rage ciwo ta hanyar CBD, CBG, THCa, da beta-caryophyllene.

Kannabinoidi ɗaya ba su isa ba. Matsalolin da Bentley ya fuskanci suka buƙaci haɗin kannabinoidi. CBD kawai ba zai iya magance rashin haɗin kai a cikin kai, matsalar tunani, glaucoma, da ciwon gwìwa a lokaci guda ba. Kannabinoidi masu karanci kamar CBG, CBN, da CBC sun zama muhimmai a cikin shekarun da Bentley ya tsufa. Ingantacciyar fasaha ta magani ta muhimmanci—rayuwar Bentley ta dogara ne akan ingantacciyar tsarin, ba hasashe ba.

Tarihin Shaxsiyyar Colin: Daga PTSD zuwa Lafiya

Colin kuma ya fahimci dogon dogon dogon dogon dogon dogon dogon dogon dogon dogon dogon dogon. Ya sha matsalar PTSD da ciwon amfani da benzodiazepine. Da ya yanke shawarar fita daga Xanax, ya yi hakan ba tare da taimako ba—wani tsari mai wuya da hatsari—ta hanyar ƙwarewar kannabinoidi da ya samar don kare rayuwar Bentley. Tsarin Peace Gummies, wanda ya zama abu na OilWell, ya samu asali a lokacin da ya yi gwaje-gwaje a dare yayinda yake yin ficewa daga ciwon amfani da benzo. Don tabbatar da samun raha mai sauri, OilWell ta kuma ba da tsarin Peace Gummies a matsayin katin vape, wanda Colin ya yi amfani da shi don magance rashin bacci da PTSD mai tsanani.

Wannan ba ilimin kimiyya ne. Colin ya rayu abin da masu amfani da RSO suke rayuwa: buƙatar samun raha, magungunan farma masu kuskure, da gano cewa kannabinoidi suna aiki inda magungunan ba su aiki ba.

Bayanin Media: Maɓallin Houston na Kanabis

Tsakanin 2019 da 2023, ABC13 Houston (KTRK)—maɓallin ABC wanda ke aiki ga babban birnin Amurka na huɗu—ya nuna Colin Valencia da OilWell Cannabis a cikin sashen labarai bakwai mai cikakkiya na kasuwanci, doka, likita, lafiya na al’umma, da siyasa. Ana neman Colin daga maƙalolin ABC13 goma sha biyar a wadannan shekaru, yana sa shi ya zama mafi bayyane mai magana kan kanabis a Houston.

Labaran Muhimman:

1. Satamba 2019: “Kasuwancin CBD na Texas yana bunƙasa yayinda kasuwa ke ci gaba da ci gaba” – Maganar asalin ta Colin: “Ba zan yi ta shawarar sayar da maganin kyauta ga mutane. Ba zan yi ta shawarar sayar da rai ga mutane. Amma akwai bincike mai yawa a nan wanda mutane kawai suke buƙatar sani kuma su gwada kuma su sami mafi kyawun abu don dogara da ra’ayoyinsu akan shi don bayyana ko ya dace ko ba da mutane ba.”
2. Maris 2021: “Mafita ya samar da kasuwanci mai zuwa ga abokin ciniki kafin a rage hukunci kan man fetur” – Ra’ayin Colin game da magani: “Mutane suna tunanin cewa duk wanda yake so ya sami rai, kuma yana da alhakin dariya da sauransu, kuma babu abin da ya dace. Amma wannan shi ne nau’in magani daban, kuma mutane suna neman abubuwa don taimakawa su da ciwon da gaske. Ciwo yana da nau’o’i da yawa.”
3. Mayu 2021: “Me shine Delta 8 THC kuma meyasa ake tunawa da shi a matsayin ‘man fetur mai doka’ a Texas?” – Gaskiyar daidaitaccen maganar Colin: “Ba zan kula ba idan za a ce ba daidai ba ne cewa za a sami rai daga shi. Wataƙila kana so ka sami rai.”
4. Agusta 2021: “Kasuwancin CBD na Houston yana ba da kyauta ga waɗanda suka samu maganin COVID” – OilWell ta ba da kyauta na pre-rolls 1,000 (kusan $35,000 na kayan aiki) don taimakawa maganin COVID-19.
5. Oktoba 2021: “Hukunci na Texas kan abu mai doka da ake amfani da shi da yawa, Delta 8, ya haifar da tambayoyi kan doka” – Colin ya cire duk kayayyakin Delta-8 daga shagunan kafin fara aiwatar da shi, yana gargaɗe wasu masu aiki waɗanda suke aika kayayyakin da ke cikin tsarin Schedule I ba tare da sani ba.
6. Oktoba 2022: “Gwamnan Amurka ya yi afuwar kanabis—fasihun sun bayyana meyasa Texas ba za ta ga sakamako ba” – Colin ya bayyana tarihin hukuncinsa na kanabis, yana kara zurfin maganar sa.
7. Afirilu 2023: “Kasuwancin kanabis yana samar da abubuwa masu ban sha’awa yayinda dokokin Texas ke ci gaba da canzawa” – Maganar Colin na “Renaissance” ta canza bayanin halin yanzu a matsayin damar kasuwancin kanabis.

Falsafar RSO na OilWell

RSO na OilWell ba shi RSO na gargajiya ba ne na Rick Simpson. Shi ne abu mai tsari, mai kannabinoidi da yawa wanda ya samo asali daga tarihin RSO amma an tsara shi don magance matsalolin da suka rage ƙarfin ra’ayin asalin na Simpson. Hanyoyi huɗu ne ke tsara hanyar mu:

1. Samun Damar Fiye da Tsari: Ba a buƙaci katin likita ba. Kowane mutum mai shekaru 21 ko fiye zai iya siyan, kuma OilWell ta aika ko inuwa da ƙasa da ƙasa.
2. Ƙarfin Dozi na Mai Amfani: THCa an siyar da shi ne a matsayinsa mai asidi, ba mai ban sha’awa ba. Mai amfani ne ya yanke shawarar ko zai yi amfani da shi a matsayinsa ko zai decarboxylate shi zuwa delta-9 THC don samun ƙarfin rai mai ban sha’awa.
3. Tsarin Abubuwan da Ba a Kulle su ba: OilWell ta wallafa tsarin abubuwan cikakkiya don kowane wanda ba zai iya siyan kayan ba zai iya samar da nau’in shi.
4. Bayani da Dogara ne akan Bayanai, Ba Bayani da Yawa ba: Mun yi alƙawarin bayyana gaskiyar abin da kimiyya ta ce, yana bambanta tsakanin abin da ake tabbatar da shi, abin da yake da tasiri, da abin da aka fi bayyana.

Kimiyyar Bayan OilWell na RSO

Hanyar Bincike da Tsarin Bayanai

Wannan sashi yana ba da matukar mahimmanci ga waɗannan tushe:

1. Bayanai na jarrabawar mutane
2. Bincike mai duba da kuma bincike na tsari
3. Bayanai na NIH da sauran gwamnati
4. Bincike na farko da kimiyya

Basisar bayanai ba ta cika ba. CBD da delta-9 THC sune da mafi ƙarfin bayanai na mutane, yayinda delta-8 THC, THCa, CBG, CBN, CBC, da yawancin terpeni suna dogara ne akan bincike na duba, na dabbobi, ko na farko.

Tsarin Bayani na Gwamnati daga NIH da Sauran

• Bayanin Mafi Inganci da aka Tabbatar: Epilepsy mai tsanani, ciwon ciki mai zuwa daga kemoterapi, da kuma shawarwari game da ciwon ciwo da rashin nauyi da ke haɗa da HIV/AIDS.
• Matsalolin Lafiya: Rashin iya aiki, hatsarin ajali a hanya, ciwon amfani da kanabis, matsalar daukar ciki, samun rauni da yara ba tare da sani ba, lalatawa ko kuskure a cikin bayani, da kuma matsalar ciwon bawa mai amfani da THC.
• Matsayin FDA: FDA ba ta amince da ganyen kanabis a matsayin magani ba, duk da cewa an amince da CBD mai tsabta (Epidiolex) da magungunan kamar THC (dronabinol, nabilone) don hanyoyi masu haske.

Kannabinoidi a Cikin RSO na OilWell

CBD

• Bayanin Bayani: Mafi ƙarfin bayani na mutane a cikin tsarin, musamman don matsalolin ciwon ƙwaƙwalwa.
• Bincike kan Baƙin Ciki: Bincike mai duba na 2024 ya gano cewa akwai alama mai muhimmanci na rage baƙin ciki, amma samfurin jarrabawa ya rage.
• Bincike kan Ciwo: Bincike mai duba na 2024 ya kammala cewa binciken ciwo ya fi dacewa, amma yana bambanta da yawa.
• Bincike kan Bacci: Bincike na 2023 ya gano cewa binciken bacci ya rage a cikin hanyar bincike.
• Matsalolin Lafiya: Haifar da ciwon ciki, zazzabi, ciwon bacci, canji a cikin sha’awa, da haɗin magunguna.

CBG

• Bayanin Bayani: Mafi yawa ne a matakin bincike na duba da na farko.
• Kimiyya: Yana bambanta da THC da CBD, yana haɗuwa da makamantansu, alpha-2 adrenoceptors, da haɗin kai da 5-HT1A.
• Sashe na Bincike: Matsalolin ƙwaƙwalwa, ciwon ciki mai zazzabi, da aiki mai tsarkakewa.
• Gargadi: CBG ana siyar da shi a kasuwa yayinda basisar bayanai ta rage.

Delta-8 THC

• Bayanin Bayani: Mai muhimmanci a cikin kimiyya, mai ban sha’awa, kuma ba a bayyana shi sosai a cikin ilimin likita fiye da delta-9 THC.
• Kimiyya mai Dacewa: Yana da kama da delta-9 THC amma ba mai ƙarfi ba saboda rashin ƙarfin haɗuwa da CB1.
• Bincike na Lafiya na Al’umma: Bincike mai duba na 2023 ya gano cewa basisar bayani ta dogara ne akan bincike a dabbobi da kimiyyar kayan aiki.
• Mahimancin Samarwa: Sha’awar delta-8 a kasuwa ta haɗuwa da ingantacciyar samuwa da sauƙin samarwa yayinda ake samun shi a cikin ganyen.

THCa

• Bayanin Bayani: Muhimmi ne a cikin kimiyya da tsari, amma bayanai na magani na mutane sun rage.
• Ban Sha’awa: THCa ba zai iya haifar da ban sha’awa ba, amma yana sauya zuwa THC ta hanyar zafi ko da zaman lafiya.
• Matsayin Bincike: Bincike a cikin kwano da na dabbobi sun nuna damar rage ciwo, aiki mai tsarkakewa, hifaztar ƙwayoyin ƙwaƙwalwa, da kuma rage ƙwayoyin cuta.

Delta-9 THC

• Bayanin Bayani: Mafi ƙarfin bayani na mutane a cikin kannabinoidi masu ban sha’awa, amma kuma mai ƙarfin sakamako na rashin lafiya.
• Bayanin Ciwo: Bincike mai duba na 2022 ya gano cewa kayayyakin THC mai yawa za su iya taimakawa a cikin rage ciwo a cikin gajeren lokaci amma za su kara ciwon baya, ciwon bacci, zazzabi, da daina magani.
• Matsalolin Lafiya na Alama: Bincike mai duba na 2025 ya gano cewa akwai haɗin kai mai ban sha’awa tare da ciwon zuciya, ciwon zuciya, da ciwon amfani da kanabis.
• Matsalolin Lafiya: Baƙin ciki, tsoro, ciwon zuciya, canjin jini, damar samun ciwo, alamomin cirewa, da matsalolin daukar ciki.

CBN

• Bayanin Bayani: Bayanin mutane ya rage; kasuwanci ta ci gaba da bayanai.
• Maganganun Bacci: Bincike mai bayani na 2021 ya gano cewa babu jarrabawar mutane ta amfani da tambayoyin bacci masu inganci ko gwajin bacci don tabbatar da maganganun rage bacci.
• Mahimancin Kimiyya: THC zai iya sauya zuwa CBN a cikin yanayi da yawa, wanda shine meyasa ake magana game da CBN a cikin kimiyyar kanabis mai tsufa ko mai lalata.

CBC

• Bayanin Bayani: Yana ci gaba, yana da ban sha’awa, kuma har yanzu yana dogara ne akan bincike na farko.
• Kimiyya: Yana bambanta da kannabinoidi masu sani, yana da damar rage ciwo, aiki mai tsarkakewa, da kuma rage ciwon ƙwaƙwalwa.
• Gargadi na Lafiya: Ana siyar da kayayyakin CBC na kasuwa yayinda babu bayanin da ya tabbatar da ingantacciyar aiki da lafiya.

Terpeni a Cikin RSO na OilWell

Maganganun terpeni suke buƙatar fahimtar daidai. Yawancin binciken terpeni ya samo asali daga kayayyakin da aka ware, mai man esensiya, ko bincike na farko, ba na jarrabawar mutane ta amfani da tsarin kanabis ba.

Limonene

• Bayanin Bayani: Mafi yawa ne a matakin bincike na duba da na farko.
• Aikin Mai Dacewa: Mai rage hargitsi, rage ciwo, hifaztar zuciya, hifaztar ciki, da kuma tsarkakewa.
• Gargadi na Lafiya: Kayayyakin da suka sauya limonene sune kayayyakin da ke haifar da ciwon fata.

Myrcene

• Bayanin Bayani: Mafi yawa ne a matakin bincike na farko, da wasu bayanai na mutane.
• Bincike: Aikin rage baƙin ciki, rage hargitsi, rage ciwo, da kuma rage ciwo.
• Gargadi a Cikin Bayani: Ana magana game da shi a matsayin terpene mai rage bacci, amma bayanai na mutane sun rage.

Caryophyllene

• Bayanin Bayani: Mai ban sha’awa a cikin kimiyya saboda haɗuwa da makamantansu na CB2.
• Sashe na Bincike: Rage ciwo, tsarkakewa, rage hargitsi, hifaztar ƙwayoyin ƙwaƙwalwa, da kuma hifaztar ciki.
• Jawabi: Dayan da ke da ƙarfin damar zama terpene mai muhimmanci a cikin tsarin kannabinoidi.

Pinene

• Bayanin Bayani: Bayanai mai ban sha’awa a cikin bincike na farko, amma bayanai na mutane sun rage.
• Mahimancin Lafiya na Ƙwaƙwalwa: Alamar rage hargitsi, rage ciwo, da kuma hifaztar ƙwayoyin ƙwaƙwalwa.
• Gargadi a Cikin Bayani: Maganganun game da tunani da lura sun rage a matsayin shawarwari.

Linalool

• Bayanin Bayani: Sha’awa mai yawa a cikin bincike na farko, amma bayanai na mutane sun rage.
• Bincike: Aiki na rage baƙin ciki, hali, da lafiya na ƙwaƙwalwa.
• Gargadi na Lafiya: Kayayyakin da suka sauya linalool sune kayayyakin da ke haifar da ciwon fata.

Humulene

• Bayanin Bayani: Yana da ban sha’awa, amma har yanzu yana a farko.
• Bincike mai Duba: Rage ciwo da sauran aiki na jiki, da wasu bincike na dabbobi sun nuna damar aiki mai kama da kannabinoidi.

Terpinolene

• Bayanin Bayani: Dayan da ke da mafi ƙarancin bayani na ilimin likita.
• Bincike mai Duba: Ana bayyana aiki na jiki da yawa, amma yawancin bincike sun kasance na na farko, na kwano, da na dabbobi.

Tsarin RSO na OilWell: An Tsara Don Afirka ta Yamma

Mai Man Sublingual na RSO

Kannabinoidi	Yawan (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
Jumla	16,590

• Terpeni Mai Rai: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Tsari: kwalba 30 mL
• Kannabinoidi Mai Aiki a kowane mL: 553 mg

Katin Vape na RSO

Kannabinoidi	Yawanci
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Terpeni Mai Rai: 5%
• Tsari: katin 1-gram

Me Yasa Wadannan Tsarin Su Muhimmi ga Afirka ta Yamma

1. Haɗin Kannabinoidi: Mutanen Afirka ta Yamma masu fama da ciwon ciwo mai tsanani, ciwon hargitsi, ko matsalolin bacci zasu samu amfani daga tsarin da ke magance hanyoyi da yawa a lokaci guda.
2. THCa don Ƙarfin Dozi na Mai Amfani: Mutanen Afirka ta Yamma waɗanda suke buƙatar aiki, tuƙi mota, ko aiki a rana zasu iya amfani da mai a matsayinsa mai asidi don samun amfani mai ban sha’awa. Waɗanda suke neman sakamako mai ban sha’awa zasu iya decarboxylate a gida.
3. Terpeni don Ingantaccen Sha’awa: Tsarin saba’in-terpene yana kara inganci da kuma damar aiki mai ban sha’awa, yana sa kayan ya fi dacewa da kuma inganci.
4. Samarwa ba tare da Mai ba: Mutanen Afirka ta Yamma zasu cancanci kayayyaki masu lafiya da kuma ba su da kayayyakin lalata.
5. Samun Damar: Ba a buƙaci katin likita ba, kuma OilWell ta aika ko inuwa da ƙasa da ƙasa.

Yadda Ake Amfani da RSO na OilWell a Afirka ta Yamma

Amfani mai Dacewa da Yanayin Ciwo

Gargadi Mai Muhimmanci: Wadannan yanayin amfani sun dogara ne akan binciken kannabinoidi da tsarin tsarin OilWell. Ba su maganin likita ba ko shawarwar FDA na maganin cuta. Koyaushe ka yi tambaya ga mai ilimin likita kafin amfani da kayayyakin kannabinoidi.

Ciwon Ciki mai Zuwa daga Kemoterapi da Taimakon Sha’awa

• Kafin Kemoterapi: 0.5–1.0 mL sublingual kusan sa’a ɗaya kafin magani.
• Ciwon Ciki mai Zuwa: 2–3 shan vape don samun raha nan take (sakamako a cikin minti 1–2).
• Bayan Kemoterapi: 0.5 mL sublingual a kowane awa shida yayin buƙatar.
• Taimakon Bacci: 1.0–2.0 mL sublingual kafin yin bacci (yana ba da 25–50 mg CBN).

Ciwon Ciwo mai Tsanani (Fibromyalgia, Ciwon Gwìwa, Ciwon Ƙwaƙwalwa)

• Rana: 0.3–0.5 mL sublingual mai ban sha’awa don amfani mai tsarkakewa ba tare da rashin iya aiki ba.
• Dare: 0.5–1.0 mL sublingual mai decarboxylate don rage ciwo da taimakon bacci na CBN.
• Ciwon Ciwo mai Zuwa: Vape yayin buƙatar don samun sakamako mai sauri.

Taimakon Bacci

• Kafin Yin Bacci: 1.0–2.0 mL sublingual (yana ba da 25–50 mg CBN).

Baƙin Ciki da Matsalar Tsoro

• Rana don Samun Raha: 0.3 mL sublingual mai ban sha’awa (CBD da CBG suke magance hanyoyin baƙin ciki ba tare da rashin iya aiki ba).
• Dare: 1.0 mL sublingual don samun cikakken bayanan kannabinoidi da taimakon bacci na CBN.

Ka’idar Kara a Farko

Fara da ƙanƙanta, ci gaba da hankali. Fara da 0.25–0.5 mL sublingual kuma duba sakamakon a cikin awa 2–3 kafin kara. Sakamako ya bambanta a cikin mutane dangane da nauyin jiki, metabolizim, haɗin kai, da sauransu.

Aika da Samun Damar a Duniya: Kai RSO zuwa Afirka ta Yamma

OilWell ta samar da tsarin aikawa mai sauri na RSO a Houston kuma ta aika ko inuwa da ƙasa da ƙasa.

Aika ko Inuwa zuwa Afirka ta Yamma

OilWell ta aika ko inuwa zuwa ƙasashen da ake amfani da kayayyakin ganyen da ke da THC mai ƙarancin 0.3%. Duk kayan da ake aika ko inuwa suna da:

• Bayanai cikakki
• Takardun Gwaji (COAs)
• Takardun siyan ko inuwa don manufar customs

Gargadi Mai Muhimmanci: Mai siyan ne ya tabbatar da dokokin gida kuma ya karɓi duk hatsarin customs da dokar.

Me Yasa Samun Damar a Duniya Ya Muhimma

Rick Simpson bai iya aika mai shi ba—ba shi da doka don samar, mallaka, ko aika shi. Yau, mutanen Afirka ta Yamma zasu iya samun irin wannan mai man kanabis mai ƙarfi, mai kannabinoidi da yawa, mai tsari wanda mutum na Houston zai samu ta hanyar aikawa mai sauri. Wannan ya cika wani bangare na ra’ayin Simpson wanda ya zama ba za a iya cika shi ba a lokacin da ya rayu saboda dokar.

Kammalawa: Mustakbalin RSO a Afirka ta Yamma

Mai Man Daga Rick Simpson ya ci gaba da tafiya mai nisa tun lokacin da ya samo asali a Nova Scotia. Daga mai man mai ƙarancin inganci da aka samar da mai man daga mai mai lalata zuwa tsari mai gwaji a lab, mai kannabinoidi da yawa wanda aka tsara don ƙarƙashin mai amfani da samun damar, RSO ya ci gaba don dacewa da buƙatar masu amfani na zamani.

Ga mutanen Afirka ta Yamma waɗanda ke bincika sauye-sauye na gargajiya don ciwon ciwo mai tsanani, taimakon cuta, matsalolin bacci, ko baƙin ciki, RSO na OilWell yana ba da haɗin tarihi da canjin kimiyya. Alƙawarinmu na samun damar, ƙarfin dozi na mai amfani, tsarin abubuwan da ba a kulle su ba, da kuma ilimin kimiyya mai daidai zai tabbatar da cewa mutanen Afirka ta Yamma zasu samu mafi kyawun nau’in RSO—wani nau’i wanda ya bi ra’ayin Simpson yayinda ya magance matsalolin da suka rage ƙarfin shi na asali.

A OilWell Cannabis, mun gaskata cewa ilimi shine mafi mahimmanci don yin zaɓi mai daidai game da lafiya. Ko ka zaɓi siyan kayayyakinmu ko ka samar da nau’in ka ta hanyar tsarin abubuwanmu na ba a kulle su ba, mun nan don ba da ilimi da goyon baya da kake buƙatar.

Don ƙarin bayani ko siyan, ziyarci OilWell Cannabis ko tuntubi mu ta hanyar (832) 416-2816 ko [email protected]. Tare, za mu bincika damar RSO a Afirka ta Yamma da sauran wurare.

ENGLISH

Rick Simpson Oil (RSO) in Western Africa: The Complete Guide by OilWell Cannabis

Introduction: Why RSO Matters in Western Africa

In Western Africa, where access to advanced medical treatments can be limited and traditional healing practices remain deeply valued, Rick Simpson Oil (RSO) has emerged as a topic of growing interest. Whether you’re exploring natural alternatives for chronic pain, cancer support, or sleep disorders, RSO offers a unique approach rooted in both historical advocacy and modern cannabinoid science.

At OilWell Cannabis, we believe Western Africans deserve access to the most honest, comprehensive education about RSO—what it is, how it works, and how modern formulations have evolved to address the limitations of traditional methods. This guide will walk you through everything you need to know, from the origins of RSO to how our Houston-based company is making these products accessible to communities across Western Africa.

The Story of Rick Simpson and Traditional RSO

Who Was Rick Simpson?

Rick Simpson was a Canadian power engineer whose journey into cannabis advocacy began with personal suffering. In 1997, he suffered a serious head injury that left him with persistent tinnitus and post-concussion symptoms. When conventional medicine failed to provide relief, he turned to cannabis, which he claimed helped more than any prescription medication. However, when he asked his doctor to support or prescribe cannabis, the request was denied.

Simpson’s interest in cannabis deepened after he learned about a 1974 study funded by the U.S. National Institute of Health (NIH), which found that THC slowed tumor growth in mice. Though these findings were never replicated in human trials, they became a cornerstone of Simpson’s later advocacy. In 2003, Simpson claimed that applying concentrated cannabis oil to basal cell carcinoma lesions on his arm made them disappear within days. While this outcome was never medically verified, it became the origin story of Rick Simpson Oil (RSO) and inspired a global movement.

The Crusade: Spreading the Oil

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil for free. He gave it away to people suffering from cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more. His story gained global attention through the 2005 documentary Run From The Cure, which framed his work as a grassroots challenge to pharmaceutical and governmental interests.

Simpson’s advocacy, however, brought him into conflict with Canadian law. He was raided by the Royal Canadian Mounted Police (RCMP) in 2005 and again in 2009, facing charges for cannabis cultivation, possession, and trafficking. Despite community support, he eventually left Canada and relocated to Europe, where he continued his advocacy from abroad. In 2012, he published Phoenix Tears, a book detailing his personal story, oil-making process, and broader views on cannabis, medicine, and institutional suppression.

The Traditional RSO Protocol: Simpson’s 60-Gram, 90-Day Regimen

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver 60 grams of concentrated cannabis oil over 90 days. He described this as a cancer treatment protocol, though he also recommended it for other conditions. Here’s a detailed breakdown of the protocol:

Goal

Consume 60 grams of high-THC cannabis oil over approximately 90 days.

Titration Schedule

• Week 1: Start with a dose the size of half a grain of rice (approximately 10–15 mg of oil) three times daily. Total daily intake: 30–45 mg.
• Weeks 2–5: Double the dose every four days until reaching approximately 1 gram per day, divided into three doses.
• Weeks 5–12: Maintain 1 gram per day until the full 60 grams are consumed.

Administration Methods

• Oral (Primary): Sublingual (under the tongue) or swallowed.
• Topical (Secondary): Applied directly to skin cancers or lesions.
• Inhalation (Not Recommended as Primary): Used for immediate symptom relief but not as a primary treatment method.

Tolerance and Psychoactive Effects

Simpson claimed patients would develop tolerance to THC’s psychoactive effects within 3–4 weeks. He recommended taking initial doses at night to sleep through the most intense effects and avoiding driving or operating machinery during the titration period.

Post-Protocol Maintenance

After completing the 60-gram course, Simpson recommended a maintenance dose of 1–2 grams per month indefinitely.

Dietary and Lifestyle Recommendations

Simpson advocated for reducing sugar intake, avoiding processed foods, and improving overall nutrition, though his dietary advice was general and secondary to the oil protocol.

Important Context for Evaluating the Protocol

Simpson’s protocol was based on personal experience and anecdotal observations, not clinical trials or scientific research. Key considerations include:

• No Controlled Trial Validation: There are no published studies evaluating this protocol for cancer or other conditions.
• Unstandardized Material: Traditional RSO potency varied widely, with THC content estimated at 60–90%.
• High THC Exposure: At peak dosing, patients consumed 600–900 mg of THC daily, far exceeding doses studied in clinical settings.
• Real Risks: High THC doses carry risks of severe intoxication, anxiety, panic, tachycardia, and cannabis use disorder.
• Oncology Context: Patients with cancer are often medically complex, and using unregulated cannabis oil as a primary treatment can delay or replace proven therapies.

What Was Traditional RSO?

Traditional RSO was defined by Simpson’s method and materials, not by lab specifications or regulatory standards. Here’s what it looked like:

Source Material

Simpson used high-THC, indica-dominant cannabis strains, believing they produced better therapeutic outcomes. There was no strain standardization—the starting material varied by availability.

Extraction Solvent

Simpson used naphtha (a petroleum-based solvent) or 99% isopropyl alcohol. Neither is food-grade, and naphtha may contain toxic compounds like benzene and toluene.

Extraction Process

1. Cannabis plant material was placed in a container and covered with solvent.
2. The mixture was agitated to dissolve cannabinoids.
3. The solvent was filtered and evaporated using a rice cooker or similar device.
4. The remaining thick, dark oil was transferred into syringes for storage and dosing.

Appearance and Physical Characteristics

Traditional RSO was nearly black, thick, tar-like, and had a strong cannabis odor with possible solvent-residual smell.

Cannabinoid Profile

• THC-Dominant: Estimated at 60–90% THC, fully decarboxylated (converted from THCa to THC).
• Minor Cannabinoids: Present at natural ratios but uncontrolled and unmeasured.
• No Ratio Control: The profile depended entirely on the source plant’s genetics and growing conditions.

Terpene Content

Minimal to none. The solvent and heat process destroyed most terpenes, leaving traditional RSO as a cannabinoid-only product.

Standardization and Testing

None. Every batch was different, with no lab testing for potency or contaminants.

Residual Solvent Risk

Naphtha and isopropyl alcohol are not food-grade, and incomplete purging could leave harmful residues in the finished oil.

Simpson’s Claims vs. the Evidence

Simpson claimed that RSO could cure cancer and treat numerous other conditions, including diabetes, chronic pain, infections, glaucoma, arthritis, depression, and insomnia. However, these claims must be evaluated against the evidence:

What Simpson Was Not

Simpson was not a scientist, physician, or researcher. He had no formal training in medicine, oncology, or clinical research. His evidence consisted of personal experience and testimonials, not controlled trials or peer-reviewed studies.

What the Preclinical Literature Shows

• In Vitro Studies: THC and CBD can induce apoptosis (cell death), inhibit proliferation, and reduce angiogenesis (blood vessel formation) in certain cancer cell lines.
• Animal Studies: Some tumor-growth inhibition has been observed in mice and rats treated with cannabinoids.
• Human Trials: No clinical trial has demonstrated that RSO or any cannabis oil cures cancer. Small human trials of cannabinoids in cancer contexts (e.g., glioblastoma) have been exploratory and have not produced definitive results.

Institutional Positions

• National Cancer Institute (NCI): Acknowledges cannabinoid research but does not endorse cannabis as a cancer treatment.
• U.S. Food and Drug Administration (FDA): Has not approved any cannabis plant product for cancer treatment. Approved cannabinoid-related products are for specific indications like epilepsy and chemotherapy-related nausea.
• Health Canada: Has never approved RSO for cancer.
• National Center for Complementary and Integrative Health (NCCIH): States the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea, and HIV/AIDS appetite stimulation—not cancer cures.

What Simpson Got Right

Simpson drew attention to cannabinoids as a serious area of biomedical research at a time when most of the world was ignoring or suppressing the conversation. His advocacy helped create the political, cultural, and social conditions for the legal cannabis industry and cannabinoid research infrastructure that exists today. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

Simpson’s claim that RSO could cure cancer was not supported by human evidence when he made it, and it remains unsupported today. Encouraging patients to rely on RSO as a primary treatment in place of proven therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine.

The Evolution of Modern RSO

The term “RSO” is now used broadly across the legal cannabis industry, often referring to any full-spectrum cannabis extract sold in a syringe format. However, modern RSO has evolved substantially from Simpson’s original method. Here’s how:

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction Method	Naphtha or isopropyl alcohol	Food-grade ethanol or CO₂ methods
Cannabinoid Profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene Content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab Testing	Not available or performed	Full panel testing (potency, terpenes, pesticides, heavy metals, residual solvents, microbial)
Residual Solvents	Significant risk with naphtha	Controlled and tested
Dosing Precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product Formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa Preservation	No—fully decarboxylated by heat	Yes—THCa included as a separate ingredient at 1,500 mg
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

OilWell’s formulations are not traditional RSO. They are informed by the RSO tradition but depart from it in deliberate, evidence-motivated ways:

1. Multi-Cannabinoid Approach: Traditional RSO relied on whatever single strain the maker grew. OilWell’s formulas include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage-effect literature suggests potential benefit from cannabinoid diversity.
2. Terpene Preservation and Addition: Traditional RSO had no terpenes due to solvent and heat destruction. OilWell includes live terpenes at 5% with a specific seven-terpene profile (limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene) because terpene bioactivity is plausible and supported at the preclinical level.
3. THCa as a Separate Ingredient: Traditional RSO fully decarboxylated everything, converting all THCa into delta-9 THC. OilWell’s sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving its non-psychoactive bioactivity.
4. Reduced Delta-9 THC Dominance: Traditional RSO was overwhelmingly delta-9 THC (60–90%). OilWell’s formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing the remaining cannabinoid content across CBD, CBG, CBN, and CBC.
5. Product Format Innovation: Simpson envisioned only one format—an oral oil. OilWell offers both a 30 mL sublingual oil and a 1-gram vape cartridge, each with its own formulation acknowledging different pharmacokinetic profiles.

Solvent Safety and Extraction Evolution

Traditional RSO used naphtha or isopropyl alcohol, neither of which is food-grade. Naphtha, in particular, may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves potentially harmful residues in the finished oil.

Modern cannabis extraction uses food-grade ethanol or supercritical CO₂, which allow for complete solvent removal and testing for residual solvents using validated analytical methods. This is one of the most significant improvements in modern RSO production.

The Decarboxylation Question

Traditional RSO was fully decarboxylated, converting all THCa into delta-9 THC. OilWell’s sublingual formula preserves THCa at 1,500 mg in its acidic, non-psychoactive form. This creates three usage options for the customer:

1. Raw (Non-Psychoactive): Use the oil as-is for non-psychoactive benefits like anti-inflammatory activity.
2. Fully Activated (Home Decarboxylation): Heat the oil at 260°F (125°C) for 45–60 minutes to convert THCa into delta-9 THC, yielding approximately 1,405 mg of total delta-9 THC.
3. Vape (Auto-Decarboxylation): The vape cartridge instantly converts THCa to delta-9 THC with each inhalation, providing fast-onset relief.

This design puts the potency decision entirely in the customer’s hands, aligning with Simpson’s principle that patients should control their own medicine.

Terpene Loss in Traditional RSO

Terpenes are volatile aromatic compounds with low boiling points. The traditional RSO production process destroyed terpenes in two ways: by dissolving them into the solvent wash and by evaporating them during the high-heat solvent-removal phase. This meant traditional RSO was a cannabinoid-only product, despite being derived from a terpene-rich plant.

OilWell’s formulas include live terpenes at 5% with a defined seven-terpene profile. Each terpene has its own evidence profile, and the entourage-effect literature provides the theoretical framework for why preserving terpenes alongside cannabinoids may matter pharmacologically.

Evidence Standards Then and Now

Simpson operated in a pre-legalization, pre-lab-testing era. His methods reflected the constraints of that time, and his evidence was anecdotal. This document takes a different approach, applying a formal evidence hierarchy:

1. Human clinical evidence
2. Systematic reviews and meta-analyses
3. Institutional summaries
4. Preclinical and mechanistic literature

Where Simpson relied on personal testimony, this document relies on published literature and institutional sources.

About OilWell Cannabis: A Company Built on Compassion and Science

The Origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin’s journey began in McAllen, Texas, a city on the U.S.-Mexico border known for its economic challenges and proximity to the violence and cartel activity of Reynosa, Mexico. Growing up in this environment, Colin was exposed to both the opportunities and hardships of life along the border. By the age of sixteen, he had to leave home for good, navigating a world where many of his friends were killed or imprisoned due to the dangers of the region.

Despite these challenges, Colin did not fall into darker paths like selling harder substances. Instead, he focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. This combination of deep cannabis plant knowledge and medical-grade technical precision defines OilWell’s approach.

Bentley’s Story: The Foundation of OilWell

The company’s origin story begins with a dog named Bentley. Bentley was more than just a pet—he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered a devastating verdict: euthanasia was the only humane option. Bentley was paralyzed in his back legs, and the pain medications prescribed would have destroyed his internal organs, causing more suffering.

Refusing to give up on Bentley, Colin turned to CBD, a cannabinoid he had never explored for therapeutic use. He created a CBD golden paste—a specialized formula for pets—and administered it to Bentley. The results were nothing short of miraculous. Bentley got up, walked over to Colin, and brought him his ball to play. This was not a placebo effect—dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at the age of twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration: CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection.
• Dementia: CBC’s role in neurogenesis.
• Glaucoma: THC’s CB1 agonism for intraocular pressure reduction.
• Arthritis: Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone could not address neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Journey: From PTSD to Peace

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a notoriously difficult and dangerous process—using the cannabinoid knowledge he had developed keeping Bentley alive. The Peace Gummies formula, which became an OilWell product, was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, and the discovery that cannabinoids work when pills do not.

Media Recognition: Houston’s Go-To Cannabis Authority

Between 2019 and 2023, ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven comprehensive news segments spanning business, law, medicine, community health, and politics. Five different ABC13 reporters sought Colin out across those years, making him the most frequently cited cannabis expert in Houston.

Key Features:

1. September 2019: “Texas CBD businesses booming as industry continues to evolve” – Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”
2. March 2021: “Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization efforts” – Colin’s perspective on therapy: “People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.”
3. May 2021: “What is Delta 8 THC and why is it considered ‘legal weed’ in Texas?” – Colin’s iconic honesty: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*
4. August 2021: “Houston CBD shop giving away free products to those who get COVID vaccine” – OilWell donated 1,000 caviar pre-rolls (approximately $35,000 in product) to encourage COVID-19 vaccination.
5. October 2021: “Texas ban over once legal hemp product, Delta 8, raises questions over legality” – Colin proactively removed all Delta-8 products from shelves before enforcement began, warning other operators who were unknowingly shipping Schedule I narcotics.
6. October 2022: “Biden marijuana pardon—experts weigh in on why Texas won’t see impact” – Colin revealed his personal marijuana conviction history, adding depth to his advocacy.
7. April 2023: “Marijuana industry getting creative as Texas laws continue to change” – Colin’s “Renaissance” framing reframed the present as an opportunity for the cannabis industry.

The OilWell RSO Philosophy

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but designed to solve the problems that limited Simpson’s original vision. Four core principles define our approach:

1. Accessibility Over Gatekeeping: No medical card is required. Anyone age 21 or older can purchase, and OilWell ships nationwide and internationally.
2. Patient-Controlled Potency: THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw or decarboxylate it into delta-9 THC for full psychoactive potency.
3. Open-Source Formulas: OilWell publishes complete formulas so that anyone who cannot afford the product can source ingredients and make their own version.
4. Evidence-Informed, Not Evidence-Overstating: We commit to honest education about what the science actually says, distinguishing between what is well-supported, what is emerging, and what is overstated.

The Science Behind OilWell’s RSO Formulas

Research Method and Evidence Weighting

This section prioritizes sources in the following order:

1. Human clinical evidence
2. Systematic reviews and meta-analyses
3. NIH and other institutional summaries
4. Mechanistic or preclinical literature

The evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature, while delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews, animal work, or preclinical studies.

Institutional Baseline from NIH and Related Sources

• Strongest Established Evidence: Rare epilepsies, chemotherapy-related nausea and vomiting, and appetite/weight-loss indications associated with HIV/AIDS.
• Safety Concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination or labeling inaccuracy, and THC-vape lung-injury concerns.
• FDA Position: The FDA has not approved the cannabis plant itself for medical use, though purified CBD (Epidiolex) and synthetic THC-like drugs (dronabinol, nabilone) have specific approvals.

Cannabinoids in OilWell’s RSO

CBD

• Evidence Profile: Strongest human evidence in the formula, especially for seizure disorders.
• Anxiety Research: A 2024 systematic review found a statistically significant anxiolytic signal, but the clinical sample remains limited.
• Pain Research: A 2024 systematic review concluded that the pain literature is promising but heterogeneous.
• Sleep Research: A 2023 review found the literature remains methodologically weak.
• Safety Concerns: Liver enzyme elevation, diarrhea, sleepiness, appetite change, and drug-drug interactions.

CBG

• Evidence Profile: Mostly review-level and preclinical.
• Pharmacology: Distinct from THC and CBD, with interactions spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling.
• Potential Research Areas: Neurologic disorders, inflammatory bowel disease, and antibacterial activity.
• Caution: CBG is already being sold commercially while the evidence base remains thin.

Delta-8 THC

• Evidence Profile: Pharmacologically relevant, psychoactive, and less clinically characterized than delta-9 THC.
• Comparative Pharmacology: Similar to delta-9 THC but less potent due to weaker CB1 affinity.
• Public-Health Literature: A 2023 scoping review found the evidence base is dominated by animal studies and product chemistry.
• Manufacturing Context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels.

THCa

• Evidence Profile: Important chemically and formulation-wise, but low on direct human therapeutic evidence.
• Psychoactivity: THCa itself does not produce psychoactive effects, but it decarboxylates into THC with heating or over time.
• Research Status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities.

Delta-9 THC

• Evidence Profile: Strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden.
• Pain Evidence: A 2022 systematic review found that high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation.
• Mental-Health Risk: A 2025 systematic review found consistent unfavorable associations with psychosis, schizophrenia, and cannabis use disorder.
• Safety Concerns: Anxiety, panic, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, and pregnancy concerns.

CBN

• Evidence Profile: Weak human evidence; marketing has moved ahead of the data.
• Sleep Claims: A 2021 narrative review found no clinical trials using validated sleep questionnaires or polysomnography to substantiate sleep-promoting claims.
• Chemical Context: THC can degrade into CBN under certain conditions, which is why CBN is often discussed in aging or oxidized cannabis chemistry contexts.

CBC

• Evidence Profile: Emerging, intriguing, and still overwhelmingly preclinical.
• Pharmacology: Distinct from better-known cannabinoids, with antinociceptive, antibacterial, and anti-seizure potential.
• Safety Caveat: Over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety.

Terpenes in OilWell’s RSO

Terpene claims require strict interpretation. Much of the terpene literature comes from isolated compounds, essential oils, or preclinical models rather than controlled human studies of cannabis formulations.

Limonene

• Evidence Profile: Largely review and preclinical.
• Potential Activity: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory.
• Safety Note: Limonene oxidation products are clinically relevant contact allergens.

Myrcene

• Evidence Profile: Mostly preclinical, with limited human evidence.
• Research Summary: Anxiolytic, antioxidant, anti-inflammatory, and analgesic properties.
• Interpretation Caution: Often invoked as a sedating terpene, but human evidence is limited.

Caryophyllene

• Evidence Profile: Mechanistically interesting due to direct CB2 receptor agonism.
• Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, and gastroprotective.
• Bottom Line: One of the strongest candidates for a terpene with cannabinoid-system significance.

Pinene

• Evidence Profile: Promising preclinical literature, weak human clinical confirmation.
• Brain-Health Framing: Antioxidant, anti-inflammatory, and neuroprotective signals.
• Interpretation Caution: Claims about memory and attention remain hypotheses.

Linalool

• Evidence Profile: Substantial preclinical interest, limited clinical confirmation.
• Research Summary: Stress, mood, and brain-health pharmacology.
• Safety Note: Oxidized linalool hydroperoxides are recognized allergens.

Humulene

• Evidence Profile: Translationally interesting, but still early.
• Scoping-Review Findings: Anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties.

Terpinolene

• Evidence Profile: One of the least clinically characterized terpenes.
• Systematic-Review Findings: A range of reported biological effects, but dominated by in silico, in vitro, and animal studies.

OilWell’s RSO Formulas: Designed for Western Africa

RSO Sublingual Oil

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
Total	16,590

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active Cannabinoids per mL: 553 mg

RSO Vape Cartridge

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%
• Format: 1-gram cartridge

Why These Formulas Matter for Western Africa

1. Multi-Cannabinoid Synergy: Western Africans dealing with chronic pain, inflammation, or sleep disorders benefit from a formula that addresses multiple pathways simultaneously.
2. THCa for Patient-Controlled Potency: Western Africans who need to work, drive, or function during the day can use the oil raw for non-psychoactive benefits. Those seeking psychoactive effects can decarboxylate at home.
3. Terpenes for Enhanced Experience: The seven-terpene profile adds sensory and potential therapeutic benefits, making the product more enjoyable and effective.
4. Solvent-Free Production: Western Africans deserve products that are safe and free from harmful residues.
5. Accessibility: No medical card is required, and OilWell ships internationally to jurisdictions where hemp-derived products are legal.

How to Use OilWell’s RSO in Western Africa

Condition-Specific Usage Context

Important Disclaimer: The following usage contexts are informed by cannabinoid research and OilWell’s formulation rationale. They are not medical prescriptions or FDA-approved treatment protocols. Always consult a qualified healthcare provider before using cannabinoid products.

Chemotherapy-Related Nausea and Appetite Support

• Pre-Chemo: 0.5–1.0 mL sublingual approximately 1 hour before treatment.
• Acute Breakthrough Nausea: 2–3 vape puffs for immediate relief (1–2 minute onset).
• Post-Chemo: 0.5 mL sublingual every 6 hours as needed.
• Sleep Support: 1.0–2.0 mL sublingual before bed (delivers 25–50 mg CBN).

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3–0.5 mL raw sublingual for anti-inflammatory benefits without psychoactive impairment.
• Nighttime: 0.5–1.0 mL decarboxylated sublingual for pain relief and CBN sleep support.
• Breakthrough Pain: Vape as needed for rapid onset.

Sleep Support

• Before Bed: 1.0–2.0 mL sublingual (delivers 25–50 mg CBN).

Anxiety and Stress

• Daytime Functional Relief: 0.3 mL raw sublingual (CBD and CBG address anxiety-related pathways without impairment).
• Nighttime: 1.0 mL sublingual for full cannabinoid profile and CBN sleep support.

General Titration Principle

Start low, go slow. Begin with 0.25–0.5 mL sublingual and assess effects over 2–3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, and other factors.

Delivery and Global Accessibility: Bringing RSO to Western Africa

OilWell operates the only same-day RSO delivery system in Houston and ships nationwide and internationally.

International Shipping to Western Africa

OilWell ships internationally to jurisdictions where hemp-derived products with less than 0.3% delta-9 THC are permitted. All international packages include:

• Full documentation
• Certificates of Analysis (COAs)
• Receipts for customs purposes

Important Note: Customers are responsible for verifying local laws and accepting all customs and legal risk.

Why International Access Matters

Rick Simpson could not ship his oil anywhere—it was illegal to produce, possess, or transport. Today, Western Africans can access the same clinical-strength, multi-cannabinoid RSO formula that a Houston resident receives via same-day delivery. This completes a piece of Simpson’s vision that prohibition made impossible during his lifetime.

Conclusion: The Future of RSO in Western Africa

Rick Simpson Oil has come a long way since its origins in Nova Scotia. From a crude, unstandardized extract made with toxic solvents to a lab-tested, multi-cannabinoid formula designed for patient control and accessibility, RSO has evolved to meet the needs of modern consumers.

For Western Africans exploring natural alternatives for chronic pain, cancer support, sleep disorders, or anxiety, OilWell’s RSO offers a unique combination of historical tradition and scientific innovation. Our commitment to accessibility, patient-controlled potency, open-source formulas, and evidence-informed education ensures that Western Africans have access to the best possible version of RSO—one that honors Simpson’s legacy while addressing the limitations of his original method.

At OilWell Cannabis, we believe that education is the key to making informed decisions about your health. Whether you choose to purchase our products or make your own using our open-source formulas, we’re here to provide the knowledge and support you need.

For more information or to place an order, visit OilWell Cannabis or contact us at (832) 416-2816 or [email protected]. Together, we can explore the potential of RSO in Western Africa and beyond.

---